Pathogenesis of fibrosis: Role of TGF-β and CTGF

Current Opinion in Rheumatology

Volumn 14, Issue 6, 2002, Pages 681-685

  Ihn, Hironobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FIBROSIS; MESENCHYME CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC SCLEROSIS;

EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036838772     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200211000-00009     Document Type: Review

References (72)

1. Clark RA: Cutaneous tissue repair: basic biologic considerations. J Am Acad Dermatol 1985, 13:701-725
2. Border WA, Ruoslahti E: Transforming growth factor-β: the dark side of tissue repair. J Clin Invest 1992, 90:1-7.
3. Gospodarowicz D, Moran JS: Mitogenic effect of fibroblast growth factor on early passage cultures of human murine fibroblasts. J Cell Biol 1975, 66:451-457.
4. Cohen S, Carpenter G: Human epidermal growth factor: isolation and chemical and biologic properties. Proc Natl Acad Sci USA 1975, 72:1317-1321.
5. Rutherford RB, Ross R: Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J Cell Biol 1976, 69:196-203.
6. Beutler B, Cerami A: Cathectin and tumor necrosis factor as two sides of the same biologic coin. Nature 1986, 320:584-588.
7. Postlethwaite AE, Holness MA, Katai H, et al.: Human fibroblasts synthesize elevated levels of extracellular matrix protein in response to interleukin 4. J Clin Invest 1992, 90:1479-1485.
8. Duncun MR, Berman B: Differential regulation of collagen, glycosaminoglycan, fibronectin and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-α and β. J Invest Dermatol 1989, 92:699-706.
9. Duncun MR, Berman B: Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 1991, 97:686-692.
10. LeRoy EC, Smith EA, Kahaleh MB, et al.: A strategy for determining the pathogenesis of systemic sclerosis. Arthritis Rheum 1989, 32:817-825.
11. Gay S, Jones RE, Huang GQ, et al.: Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. J Invest Dermatol 1989, 92:301-303.
12. Peltonen J, Hsiao LL, Jaakkola S, et al.: Activation of collagen gene expression in keloids: co-localization of type I and type VI collagen and transforming growth factor-β1 mRNA. J Invest Dermatol 1991, 97:240-248.
13. Attisano L, Wrana JL: Signal transduction by members of the transforming growth factor-β superfamily. Cytokine Growth Factor Rev 1996, 7:327-339.
14. Border WA, Noble NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994, 331:1286-1292.
15. Bradham DM, Igarashi A, Potter RL, et al.: Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC induced immediate early gene product CEF-10. J Cell Biol 1991, 114:1285-1294.
16. Igarashi A, Okochi H, Bradham DM, et al.: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993, 4:637-645.
17. Shinozaki M, Kawara S, Hayashi N, et al.: Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor β: simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun 1997, 240:292-297.
18. Mori T, Kawara S, Shinozaki M, et al.: Role and interaction of connective tissue growth factor with transforming growth factor β in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 1999, 181:153-159.
19. Igarashi A, Nashiro K, Kikuchi K, et al.: Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995, 105:280-284.
20. Igarashi A, Nashiro K, Kikuchi K, et al.: Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996, 106:723-733.
21. Massague J: TGF-β signal transduction. Ann Rev Biochem 1998, 67:753-791.
22. Nunes I, Gleizes PE, Metz CN, et al.: Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J Cell Biol 1997, 136:1151-1163.
23. Massgue J: The transforming growth factor-β family. Ann Rev Cell Biol 1990, 6:597-641.
24. Kulozik M, Hogg A, Lankat-Buttgereit B, et al.: Co-localization of transforming growth factor β2 with α1(I) procollagen mRNA in tissue section of patients with systemic sclerosis. J Clin Invest 1990, 86:917-922.
25. Ihn H, Yamane K, Kubo M, et al.: Blockade of endogenous transforming growth factor β signaling prevent upregulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor β receptors. Arthritis Rheum 2001, 44:474-480.
26. Needleman BW, Choi J, Burrows-Menzu A, et al.: Secretion and binding of transforming growth factor β by scleroderma and normal dermal fibroblasts. Arthritis Rheum 1990, 33:650-653.
27. Wrana JL, Attisano L, Weisser R, et al.: Mechanism of activation of the TGF-β receptor. Nature 1994, 370:341-347.
28. Saitoh M, Nishitoh H, Amagasa T, et al.: Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor β. J Biol Chem 1996, 271:2769-2775.
29. Kawakami T, Ihn H, Xu W, et al.: Increased expression of TGF-β receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype. J Invest Dermatol 1998, 110:47-51.
30. Kubo M, Ihn H, Yamane K, et al.: upregulated expression of transforming growth factor β receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum 2001, 44:731-734.
31. Roulot D, Sevcsik AM, Coste T, et al.: Role of transforming growth factor β type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology 1999, 29:1730-1738.
32. Qi Z, Atsuchi N, Ooshima A, et al.: Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 1999, 96:2345-2349.
33. Massague J, Chen YG: Controlling TGF-β signaling. Genes Dev 2000, 14:627-644.
34. Shi Y, Hata A, Lo RS, et al.: A structure basis for mutational inactivation of the tumor suppressor Smad4. Nature 1997, 388:87-93.
35. Zawel L, Dai JL, Buckhaults P, et al.: Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1998, 1:611-617.
36. Imamura T, Takase M, Nishihara A, et al.: Smad6 inhibits signaling by the TGF-β superfamily. Nature 1997, 389:622-626.
37. Ihn H, Tamaki K: Increased phosphorylation of transcription factor Spl in scleroderma fibroblasts: association with increased expression of type I collagen gene. Arthritis Rheum 2000, 43:2240-2247.
38. Ihn H, Ohnishi K, Tamaki T, et al.: Transcriptional regulation of the human α2(I) collagen gene: combined action of upstream stimulatory and inhibitory cis-acting element. J Biol Chem 1996, 271:26717-26723.
39. Ihn H, LeRoy EC, Trojanowska M: Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site. J Biol Chem 1997, 272:24666-24672.
40. Ihn H, Trojanowska M: Sp3 is a transcriptional activator of the human α2(I) collagen gene. Nucleic Acids Res 1997, 25:3712-3717.
41. Ihn H, Tamaki K: Competition analysis of the human α2(I) collagen promoter using synthetic oligonucleotides. J Invest Dermatol 2000, 114:1011-1016.
42. Ihn H, Ihn Y, Trojanowska M: Sp1 phosphorylation induced by serum stimulates the human α2(I) collagen gene. J Invest Dermatol 2001, 117:301-308.
43. Inagaki Y, Truter S Ramirez F: Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994, 269:14828-14834.
44. Greenwel P, Inagaki Y, Hu W, et al.: Sp1 is required for the early response of α2(I) collagen to transforming growth factor-β1. J Biol Chem 1997, 272:19738-19745.
45. Chen SJ, Yuan W, Mori Y, et al.: Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: involvement of Smad3. J Invest Dermatol 1999, 112:49-57.
46. Chen SJ, Yuan W, Lo S, et al.: Interaction of Smad3 with proximal Smad-binding element of the human α2(I) collagen gene promoter required for transcriptional activation by TGF-β. J Cell Physiol 2000, 183:381-392.
47. Mori Y, Chen SJ, Varga J: Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β. Exp Cell Res 2000, 258:374-383.
48. Zhang W, Ou J, Inagaki Y, et al.: Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor-β1 stimulation of α2(I) collagen (COL1A2) transcription. J Biol Chem 2000, 275:39237-39245.
49. Poncelet AC, Schnaper HW: Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangial cells. J Biol Chem 2001, 276:6983-6992.
50. Inagaki Y, Nemoto T, Nakao A, et al.: Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J Biol Chem 2001, 276:16573-16579.
51. Ghosh AK, Yuan W, Mori Y, et al.: Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000, 19:3546-3555.
52. Ghosh AK, Yuan W, Mori Y, et al.: Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β. Integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 2001, 276:11041-11048.
53. Czuwara-Ladykowska J, Sementchenko VI, Watson FK, et al.: Ets1 is an effector of the TGF-β signaling pathway and an antagonist of the profibrotic effects of TGF-β. J Biol Chem 2002, in press
54. Yuan W, Varga J: Tansforming growth factor-β repression of matrix metalloproteinase 1 in dermal fibroblasts involves Smad3. J Biol Chem 2001, 276:38502-38510.
55. Flanders KC, Sullivan CD, Fujii M, et al.: Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 2002, 160:1057-1068.
56. Zhao J, Shi W, Wang YL, et al.: Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2002, 282:585-593.
57. Lee DK, Park SH, Yi Y, et al.: The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 2001, 15:455-466.
58. Schnabl B, Kweon YO, Frederick JP, et al.: The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 2001, 34:89-100.
59. Inagaki Y, Mamura M, Kanamaru Y, et al.: Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic satellate cells. J Cell Physiol 2001, 187:117-123.
60. Takahashi Y, Matsuzaki K, Date M, et al.: Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002, 35:49-61.
61. Terada Y, Hanada S, Nakao A, et al.: Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. Kidney Int 2002, 61:94-98.
62. Dong C, Zhu S, Wang T, et al.: Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc Natl Acad Sci USA 2002, 99:3908-3913.
63. Segar R, Krebs EG: The MAPK signaling cascade. FASEB J 1995, 9:726-798.
64. Ihn H, Tamaki K: Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J Immunol 2000, 165:2149-2155.
65. Ihn H, Yamane K, Asano Y, et al.: IL-4 upregulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase-dependent pathway. J Immunol 2002, 168:1895-1902.
66. Sato M, Shegogue D, Gore EA, et al.: Role of p38 MAPK in transforming growth factor β stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J Invest Dermatol 2002, 118:704-711.
67. Frazer K, Williams SKD, Klapper H, et al.: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996, 107:404-411.
68. Paradis V, Dargere D, Vidaud M, et al.: Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999, 30:968-976.
69. Ziesche R, Hofbauer E, Wittmann K, et al.: A preliminary study of long-term treatment with interferon γ-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999, 341:1264-1269.
70. Abou-Shady M, Freiss H, Zimmermann A, et al.: Connective tissue growth factor in human liver cirrhosis. Liver 2000, 20:296-304.
71. Chen MM, Lam A, Abraham JA, et al.: CTGF expression is induced by TGF-β in cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000, 32:1805-1819.
72. Stratton R, Shiwen X, Martini G, et al.: Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001, 108:241-250.